Genetically engineered nanovesicles for theragnostic treatments
Through our Ntracle system, various inflammatory-related diseases, including initiation and development of arteriosclerosis, can be effectively inhibited.
Thermo-sensitive biodegradable platform for controlled delivery
Through our Nhygel platform, a wide range of therapeutic molecules and drug agents can be effectively administered to the local targeting place.
Innovative treatment systems with maximal efficacy and safety
Through its pioneering platform-based biotechnology, Numais Co.,LTD aims to develop unprecedented treatment systems.
The vision of Numais Co., Ltd.
Is to build fundamental knowledge and to
establish the state-of-the-art synthesis
Based on its integrative stem-cell culture, nanovesicle fabrication, and bio-compatible polymer synthesis technologies, Numais Co., Ltd. endeavors towards the world-best medical products.READ MORE